Trusight Software Suite News Today : Breaking News, Live Updates & Top Stories | Vimarsana

As per the report by Fortune Business Insights, the global Genomics Market size is projected to reach USD 94.65 billion in 2028, at a CAGR of 19.4% during...

Illumina, Emedgene Launch AI-Based Rare Disease Interpretation Partnership Illumina has launched a nonexclusive partnership with Emedgene, an artificial intelligence-based precision medicine company, to integrate automated interpretation of rare genetic disease data into Illumina’s TruSight™ Software Suite. Through the collaboration, whose value has not been disclosed, TruSight will include Emedgene’s clinical rare disease application, one of a portfolio of artificial intelligence (AI)-powered applications for high-throughput genomic interpretation across clinical and research use cases...

Emedgene collaborates with Illumina to scale the interpretation of genomic data for rare diseases USA - English News provided by Share this article Share this article PALO ALTO, California, Dec. 16, 2020 /PRNewswire/ -- Emedgene, a leading precision medicine intelligence company, announces a non-exclusive partnership with Illumina Inc. and the integration of automated interpretation into Illumina's TruSight™ Software Suite for rare genetic diseases. Emedgene's Clinical Rare Disease application is one of a portfolio of artificial intelligence (AI)-powered applications for high-throughput g...